Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. (AMPE) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
AMPE · net income · updated Jun 8, 2026
Core profitability metrics
AMPE · net income · margin · TTM · CAGRNet income was −$8.6M for FY2023 (fiscal year ending 2023-12-31), up 47.2% year-over-year. Net profit margin was —. Based on available data, Ampio Pharmaceuticals, Inc. has been profitable since at least 2018.
Annual net income history
▸ FMP /income-statement · Annual · AMPE net income history · AMPE profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Ampio Pharmaceuticals, Inc. (AMPE) reported net income of −$8.6M for FY2023 (fiscal year ending 2023-12-31), up 47.2% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Based on available data, Ampio Pharmaceuticals, Inc. has been profitable since at least 2018. Net income reached a peak of $34.0M in FY2018. Data available for 15 fiscal years.
Ampio Pharmaceuticals, Inc.'s net profit margin was — for FY2023, based on the latest annual results.
Investors sometimes search for "Ampio Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from AMPE net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
AMPE net income · 4 questionsAmpio Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $8.6M for FY2023.
▸ Source: FMP /income-statement · GAAP · Ampio Pharmaceuticals, Inc. · Ampio Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026